GTHP Projected Dividend Yield

Com Par $0.001 (New)/Guided Therapeutics Inc ( OTCBB : GTHP )

Guided Therapeutics is a medical technology company focused on developing medical devices that have the potential to improve healthcare. Co. is primarily focused on its LuViva® Advanced Cervical Scan non-invasive cervical cancer detection device. The technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. Co. focuses on two primary applications for LuViva: as a cancer screening tool; and as a triage following conventional screening.

20 YEAR PERFORMANCE RESULTS